Glycobiology, Vol 8, 885-890, Copyright © 1998 by Society for Glycobiology
BK Gillard, RG Clement and DM Marcus
There are several pathways for the incorporation of sugars into
glycosphingolipids (GSL). Sugars can be added to ceramide that contains
sphinganine (dihydrosphingosine) synthesized de novo (pathway 1), to
ceramide synthesized from sphingoid bases produced by hydrolysis of
sphingolipids (pathway 2), and into GSL recycling from the endosomal
pathway through the Golgi (pathway 3). We reported previously the
surprising observation that SW13 cells, a human adrenal carcinoma cell
line, synthesize most of their GSL in pathway 2. We now present data on the
synthesis of GSL in four additional cell lines. Approximately 90% of sugar
incorporation took place in pathway 2, and 10% or less in pathway 1, in
human foreskin fibroblasts and NB41A3 neuroblastoma cells. In contrast,
approximately 50-90% of sugar incorporation took place in pathway 1 in
C2C12 myoblasts. The C2C12 cells divide more rapidly and synthesize 10-14
times as much GSL as the other three cell lines. In C6 glioma cells,
approximately 30% of sugar incorporation occurred in pathway 1 and 60% in
pathway 2. There was no relation between the utilization of pathways for
GSL and sphingomyelin synthesis in foreskin fibroblasts and C2C12 cells. In
both cells pathways 1 and 2 each accounted for 50% of incorporation of
choline into sphingomyelin. In five of the six cell lines that we have
studied, most GSL synthesis takes place in pathway 2. We suggest that when
the need for synthesis is relatively low, as in slowly dividing cells, GSL
are synthesized predominantly from sphingoid bases salvaged from the
hydrolytic pathway. When cells are dividing more rapidly, the need for
increased synthesis is met by upregulating the de novo pathway.
ORIGINAL ARTICLES
Variations among cell lines in the synthesis of sphingolipids in de novo and recycling pathways
Department of Medicine, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Kitatani, K. Sheldon, V. Rajagopalan, V. Anelli, R. W. Jenkins, Y. Sun, G. A. Grabowski, L. M. Obeid, and Y. A. Hannun Involvement of Acid {beta}-Glucosidase 1 in the Salvage Pathway of Ceramide Formation J. Biol. Chem., May 8, 2009; 284(19): 12972 - 12978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Le Stunff, P. Giussani, M. Maceyka, S. Lepine, S. Milstien, and S. Spiegel Recycling of Sphingosine Is Regulated by the Concerted Actions of Sphingosine-1-phosphate Phosphohydrolase 1 and Sphingosine Kinase 2 J. Biol. Chem., November 23, 2007; 282(47): 34372 - 34380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Coursol, H. Le Stunff, D. V. Lynch, S. Gilroy, S. M. Assmann, and S. Spiegel Arabidopsis Sphingosine Kinase and the Effects of Phytosphingosine-1-Phosphate on Stomatal Aperture Plant Physiology, February 1, 2005; 137(2): 724 - 737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. P. Becker, K. Kitatani, J. Idkowiak-Baldys, J. Bielawski, and Y. A. Hannun Selective Inhibition of Juxtanuclear Translocation of Protein Kinase C {beta}II by a Negative Feedback Mechanism Involving Ceramide Formed from the Salvage Pathway J. Biol. Chem., January 28, 2005; 280(4): 2606 - 2612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Chigorno, C. Giannotta, E. Ottico, M. Sciannamblo, J. Mikulak, A. Prinetti, and S. Sonnino Sphingolipid Uptake by Cultured Cells: COMPLEX AGGREGATES OF CELL SPHINGOLIPIDS WITH SERUM PROTEINS AND LIPOPROTEINS ARE RAPIDLY CATABOLIZED J. Biol. Chem., January 28, 2005; 280(4): 2668 - 2675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. t. Vruchte, E. Lloyd-Evans, R. J. Veldman, D. C. A. Neville, R. A. Dwek, F. M. Platt, W. J. van Blitterswijk, and D. J. Sillence Accumulation of Glycosphingolipids in Niemann-Pick C Disease Disrupts Endosomal Transport J. Biol. Chem., June 18, 2004; 279(25): 26167 - 26175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. De Rosa, D. Sillence, C. Ackerley, and C. Lingwood Role of Multiple Drug Resistance Protein 1 in Neutral but Not Acidic Glycosphingolipid Biosynthesis J. Biol. Chem., February 27, 2004; 279(9): 7867 - 7876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Le Stunff, I. Galve-Roperh, C. Peterson, S. Milstien, and S. Spiegel Sphingosine-1-phosphate phosphohydrolase in regulation of sphingolipid metabolism and apoptosis J. Cell Biol., September 16, 2002; 158(6): 1039 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Allende, J. Li, D. S. Darling, C. A. Worth, and W. W. Young Jr. Evidence supporting a late Golgi location for lactosylceramide to ganglioside GM3 conversion Glycobiology, October 1, 2000; 10(10): 1025 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wendeler, T. Kolter, and K. Sandhoff Pathology of Glycosphingolipid Metabolism: The Molecular and Cellular Basis of Neurodegenerative Disease Neuroscientist, August 1, 2000; 6(4): 285 - 296. [Abstract] [PDF]
|
|
|
|
|
|
Y. Nakatani, T. Tanioka, S. Sunaga, M. Murakami, and I. Kudo Identification of a Cellular Protein That Functionally Interacts with the C2 Domain of Cytosolic Phospholipase A2alpha J. Biol. Chem., January 14, 2000; 275(2): 1161 - 1168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Chammas, J. L. Sonnenburg, N. E. Watson, T. Tai, M. G. Farquhar, N. M. Varki, and A. Varki De-N-acetyl-gangliosides in Humans: Unusual Subcellular Distribution of a Novel Tumor Antigen Cancer Res., March 1, 1999; 59(6): 1337 - 1346. [Abstract] [Full Text] [PDF]
|
|